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(Abstract) 
Prior research has related dispositional optimism to physical health. Traditionally, 
dispositional optimism is treated as a bipolar construct, anchored at one end by optimism and the 
other by pessimism. Optimism and pessimism, however, may not be diametrically opposed, but 
rather may reflect two independent, but related dimensions. This paper reports a reanalysis of 
data from previously published studies on dispositional optimism. The reanalysis was designed 
to evaluate whether the presence of optimism or the absence of pessimism predicted positive 
physical health more strongly. Relevant literatures were screened for studies relating 
dispositional optimism to physical health. Authors of relevant studies were asked to join a 
consortium, the purpose of which was to re-analyze previously published data sets separating 
optimism and pessimism into distinguishable components. Ultimately, data were received from 
61 separate samples (N = 221,133). Meta-analytic analysis of data in which optimism and 
pessimism were combined into an overall index (the typical procedure) revealed a significant 
positive association with an aggregated measure of physical health outcomes (r = .026, p < .001), 
as did meta-analytic analyses with the absence of pessimism (r = .029, p < .001) and the 
presence of optimism (r = .011, p < .034) separately. The effect size for pessimism was 
significantly larger than the effect size for optimism (Z = -2.403, p < .02). Thus, the absence of 
pessimism was more strongly related to positive health outcomes than was the presence of 
optimism. Implications of the findings for future research and clinical interventions are 
discussed. 
Keywords: Optimism, pessimism, physical health, meta-analytic methodology 
Public Significance Statement: Prior research on dispositional optimism typically combines the 
presence of optimism and the absence of pessimism into an overall index. Prior research using 
this combined index suggests that dispositional optimism is associated with better physical 
health. The present reanalysis of existing data breaks apart the two components of dispositional 
optimism and suggests that the absence of pessimism is more strongly related to good physical 
health than is the presence of optimism.  
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Folk wisdom has long held that differences among people in optimism and pessimism are 
important to many aspects of daily living. In this case, folk wisdom seems to be right. Optimists 
have been documented to differ from pessimists in many important ways. They differ in how 
they approach and cope with the problems they confront (Nes & Segerstrom, 2006), the number 
and quality of relationships they form (Assad et al., 2007; Brissette, Scheier, & Carver, 2002), 
and the quality of life they experience (Duffy et al., 2013; Segerstrom, Carver, & Scheier, 2017).  
Optimists and pessimists also differ in their physical health. For the past 3 decades, 
research on dispositional optimism and physical health has flourished. A Google Scholar search 
for “dispositional optimism” and “physical health” yields over 5,000 hits. Dispositional 
optimism predicts a number of short-term and long-term health outcomes, including 
rehospitalization after surgery (Scheier, Matthews, Owens, et al., 1999; Tindle, Belnap, Hum, et 
al., 2012), incident cardiovascular disease (Tindle, Chang, Kuller, et al., 2009), incident stroke 
(Kim, Park, & Peterson, 2011), and mortality (Kim, Hagan, Grodstein, et al., 2016; Tindle et al., 
2009). It is also related to a number of biological markers tied to disease endpoints, including 
ambulatory blood pressure (Räikkönen, Matthews, Flory, et al., 1999), cortisol secretion (Jobin, 
Wrosch, & Scheier, 2013), as well as levels of lipids (Boehm, Williams, Rimm, et al., 2013a) 
and anti-oxidants (Boehm, Williams, Rimm, et al., 2013b). 
 Although links between dispositional optimism and physical health now seem well-
established (for a general quantitative review see, Rasmussen, Scheier, & Greenhouse, 2009; for 
a general qualitative review see, Boehm & Kubzanksy, 2012), how best to construe the construct 
of optimism has proven more controversial. Most of the research that has been conducted on 
dispositional optimism treats the variable as bipolar in nature, anchored at one end by optimism 
(the generalized expectancy that favorable outcomes will occur in the future) and at the other end 
by pessimism (the generalized expectancy that unfavorable outcomes will occur in the future). 
According to this view, as someone moves away from optimism that person necessarily moves 
more toward pessimism.  
 This prevailing view has emerged in part because of the way in which the scales used to 
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measure dispositional optimism are scored. The two most widely used scales to measure 
dispositional optimism are the Life Orientation Test (LOT, Scheier & Carver, 1985) and the Life 
Orientation Test—Revised (LOT-R, Scheier, Carver, & Bridges, 1994). Each of these scales 
contains two sets of items. Items from one set are framed in a positive way (assessing the 
affirmation of optimism or not), and items from the second set are framed in a negative way 
(assessing the affirmation of pessimism or not). Typically, the negatively framed items are 
reverse coded and then added to the positively framed items to produce on overall scale score. 
Some researchers have questioned the validity of this “bipolar” point of view. Interest in 
the question arose after several factor analyses suggested that a 2-factor model of the items on 
the LOT and LOT-R fit the data better than did a model with a 1-factor solution (e.g., Chang & 
McBride-Chang, 1996; Hjelle, Belongia, & Nesser, 1996). In these analyses, items assessing 
expectations for positive outcomes loaded on one factor (an “optimism” factor reflecting the 
affirmation of optimism or not), whereas items assessing expectations for negative outcomes 
loaded on a second factor (a “pessimism” factor, reflecting the affirmation of pessimism or not). 
Consistent with the factor analytic results, correlations between the optimism and pessimism 
subscales are modest (Mens, Scheier, & Carver, 2016). 
Conceptually, it makes sense that optimism and pessimism are somewhat distinct. Clearly, 
someone who is not pessimistic is not necessarily optimistic. It only means that there is an 
absence of pessimism. Similarly, someone who is not optimistic is not necessarily pessimistic. It 
just means that there is an absence of optimism. People can be neither optimistic nor pessimistic. 
This is one reason why the two factors are thought to reflect the presence or absence of the 
characteristic in question. Consistent with this construal, the same terminology is used 
throughout this paper to refer to the two ends of the optimism and pessimism dimensions. 
There are differences in opinion about what to make of the factor-analytic studies. 
Monzani, Steca, and Greco (2014) believe that the two factors are due to response style and that 
optimism should still be conceptualized as a single dimension. Others have argued that optimism 
and pessimism are distinct properties that may have differential effects on various aspects of 
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physical health (e.g., Kubzansky et al., 2004). Several attempts have used item response theory 
to resolve the issue. This research suggests that a single dimension may fit the LOT-R better (e.g. 
Steca, Monzani, Greco, Chiesi, & Primi, 2014). However, the issue is far from resolved 
psychometrically. 
Research from the field of behavior genetics offers further support for the idea that 
optimism and pessimism are distinguishable. A variety of studies now support the idea that there 
is a genetic basis for differences in dispositional optimism (e.g., Caprara et al., 2009; Plomin et 
al., 1992). More importantly, there is also some evidence that the genetic origins of optimism 
and pessimism might be slightly different. For example, Plomin et al., (1992) have shown that 
shared environment is more important for optimism than pessimism.  Using more complex 
modeling techniques, Bates (2015) has shown that optimism and pessimism contain genetic 
variation that separates them from both the Big 5 personality factors and from each other. 
Recent research in health psychology also contributes to the discussion of dimensionality 
by documenting that optimism and pessimism can be related to physical health differentially. For 
example, research suggests that it is pessimism that produces associations with inflammation, not 
optimism (Roy et al., 2010, Ikeda et al., 2011; O’Donovan et al., 2009). Pessimism was also 
found to be a stronger predictor than optimism of in vitro fertilization success (Bleil et al., 2012). 
In contrast, Kim et al. (2011) showed that optimism, but not pessimism, predicted incidence of 
stroke. Although only a handful of studies speak directly to this issue, the available evidence 
tends to suggest that the absence of pessimism might be a more important contributor to 
associations with physical health than the presence of optimism. Clearly, however, more research 
is needed on this issue. 
In this regard, an organization called the Optimism/Pessimism Meta-Analytic Consortium 
(OPMAC) was formed to pool data from across studies to examine more systematically the 
effects of optimism and pessimism on physical health. Each member of the consortium has 
reanalyzed data from a previously published study in such a way that the effects of optimism and 
pessimism can be separated and compared. The purpose of this paper is to present the results of 
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the reanalyses that were conducted on the novel data that OPMAC members provided. Given the 
trend of the few available studies published prior to the present reanalyses, the absence of 
pessimism was expected to be a stronger predictor of positive physical health than was the 
presence of optimism. 
Method 
Literature Search Strategy and Inclusion/Exclusion Criteria 
To identify relevant researchers to contact, literature searches were performed on the 
MedLINE and PsycINFO databases for relevant studies published in English-language peer-
reviewed journals up until December 31st 2016 using combinations of the following keywords: 
optimism, pessimism, Life Orientation Test , LOT, Life Orientation Test—Revised, LOT-R, 
immune, inflammation, HIV or AIDS, arthritis, osteoarthritis, lupus, autoimmune, multiple 
sclerosis, pregnancy, infertility, cancer or neoplasms, cortisol, blood pressure, atherosclerosis, 
cardiovascular, coronary, heart, infarction, stroke, diabetes, glycemic, anemia, respiratory, 
tuberculosis, dementia, asthma, Huntington’s, renal, kidney, influenza, pneumonia, cold, ulcer, 
sleep, survival, death, mortality, body mass index, wound, surgery, and metabolic. The search 
terms used to identify studies were largely derived from a meta-analysis of the same area 
conducted by Rasmussen et al. (2009), with extra terms added to capture biomarkers more fully. 
Review papers and references from relevant articles were used to identify additional studies of 
interest. After an initial prescreening for potentially relevant articles, based on the study title and 
abstract, a total of 549 full-length manuscripts were downloaded for further evaluation based on 
our inclusion and exclusion criteria. 
Manuscripts were included for consideration if they met two inclusion criteria. First, the 
study utilized the LOT (Scheier & Carver, 1985), the LOT-R (Scheier et al., 1994), or a validated 
translation or adaptation of either the LOT or LOT-R (e.g. the Parent-rated Life Orientation Test 
of children, Lemola et al., 2010). This criterion was enacted because the objective of the present 
set of reanalyses was to evaluate the differential effects of optimism and pessimism on physical 
health. The LOT and LOT-R are the only scales available that allow for overall/combined 
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optimism to be deconstructed into its underlying components. The LOT-R was created in order 
to remove two coping items that had been included in the original LOT. The LOT and the LOT-
R correlate in the low .90’s (Scheier et al., 1994). The psychometric properties of the LOT and 
LOT-R are well established (for a review, see Carver & Scheier, 2019), and they are used widely 
in the literature in health psychology. An example of a positively worded item is, “In uncertain 
times, I usually expect the best.” An example of a negatively worded item is, “I hardly ever 
expect things to go my way.” All items are answered along a 5-point Likert scale, ranging from 
“strongly disagree” at one end to “strongly agree” at the other. 
Second, the study included an objective measure of physical health. Objective measures of 
physical health included biomarkers of various types (e.g., systolic and diastolic blood pressure, 
cortisol reactivity), disease incidence (e.g., stroke, acute myocardial infarction, diabetes, cancer), 
hospital stay or rehospitalization, and survival or mortality. Review papers, unpublished data, 
dissertations, and conference abstracts were not included.  
Two additional exclusion criteria were also used. First, studies were excluded if neither 
optimism/pessimism nor physical health were the primary focus of the study (the vast majority of 
these studies had simply included optimism or physical health as part of a wider set of 
covariates). The decision to exclude these studies was made largely on the basis of expected 
utility. That is, to provide useful data for the present reanalyses authors were required to 
reanalyze the data from their studies, breaking optimism and pessimism down into separate 
factors (the norm for published studies is to combine these components into an overall score). If 
the primary theoretical frameworks of authors were related to neither optimism/pessimism nor 
physical health, it seemed unlikely that they would put the needed effort into providing data for 
the reanalyses. For this reason, they were not pursued further. 
Studies of primary interest in this analysis were those conducted in the field, often over 
prolonged periods of time. Consequently, studies were also excluded if they represented 
experimental laboratory studies that consisted of a single session, in which participants were 
randomly assigned to conditions. These studies were excluded because they were thought to be 
  Optimism, Pessimism, and Health 
 8 
too dissimilar to the larger set of field studies of primary interest. Including them would have 
made interpretation of results difficult.  
Upon evaluating the 549 downloaded manuscripts, 189 relevant studies were identified that 
met our inclusion and exclusion criteria. Of these 189 studies, 16 were removed because they 
provided duplicate data across time. These papers tended to provide interim reports of ongoing 
longitudinal studies. The rule for serial publication of results was to take the longest follow-up 
time available. An additional 10 studies were removed because no email was provided for the 
original authors. Four studies were removed because the measure of optimism was assessed after 
the measure of physical health. The corresponding authors of the remaining 159 manuscripts 
were contacted and asked if they had an interest in joining the consortium.  
Of the authors contacted, 44 did not respond to our request, and 50 reported that the date 
were no longer available. In addition, there were 2 cases (Ai, Seymore, & Tice, 2009; Lai, 
Evans, & Ng, 2005) for which incorrect analyses had been requested. Because the error was 
discovered late in the process of data analysis, these authors were not asked to provide corrected 
data. Finally, one study (Bennett et a., 2015) was excluded because the researchers only collected 
data on the optimism subscale, and data from both subscales were needed to conduct analyses. 
Ultimately, the data from 62 papers were available for inclusion in the present reanalyses. 
Two pairs of these studies (Pänkäläinen et al., 2015 and Pänkäläinen et al., 2016, and Ruiz et al., 
2003 and Scheier et al., 1999) reported on the same sample, but included different outcomes 
from one paper to the next. These two pairs of studies were included in the analyses, but the data 
from the pairs of studies were considered to be dependent for purpose of analysis. That is, they 
were treated as providing multiple outcomes from the same sample. Another study (Konkoly-
Thege et al., 2015) provided separate, independent samples in the same paper (one comprised of 
healthy controls and one comprised of patients). These samples were treated as independent in 
the analyses. Thus, a total of 61 independent samples was ultimately available for inclusion in 
the present reanalyses (see Figure 1 for a graphic display of the study selection process). 
Data Collection 
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Initial contact. Potential consortium members were contacted by email, informed of the 
purpose of the present project, told what additional analyses needed to be performed, and invited 
to join the effort. If no response was received, a second email was sent with the same 
information 2 to 4 weeks later. If no response was received to the second email, a third email was 
sent 2 to 4 weeks later. If no response was received to the third email, recipients were identified 
as non-responders. Recipients were also identified as non-responders if, after a corresponding 
author expressed interest in contributing their data, at least two months had passed without 
receiving the requested data and no response was given to a follow-up email regarding the status 
of their analyses.  
The data collection process began on August 11, 2016. All data were received by May 31, 
2017. Recipients who participated were given $200 as a token of appreciation for their effort and 
were entered into the Optimism/Pessimism Meta-Analytic Consortium (OPMAC). Consortium 
members are listed in Supplemental Online Table 1. 
Requested analyses. Each consortium member was asked to conduct three separate 
analyses, one using the overall/combined optimism score as the predictor variable, one using the 
pessimism subscale as the predictor variable, and one using the optimism subscale as the 
predictor variable. All analyses treated optimism and pessimism as continuous variables. Items 
were recoded so that a high score indicated high optimism (for the overall/combined scale and 
the optimism subscale) or low pessimism (for the pessimism subscale). Effect sizes were coded 
such that a positive effect size indicated better health. Thus, the overall/combined scale, the 
optimism subscale, and the pessimism subscale should all be related in a positive manner with 
the health outcomes assessed. 
If a published study contained physical health outcomes in the primary outcomes reported, 
those same physical health measures were requested as outcomes in the re-analysis. If a 
published study contained physical health outcomes, but did not report them as primary 
outcomes, all relevant physical health measures included in the study were requested as 
outcomes in the re-analysis. Relevant physical health measures were defined as those which had 
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been used as a primary outcome in at least one other study in the pool of studies in the analysis. 
This strategy was employed in order to avoid including an abundance of studies with 
idiosyncratic outcomes (i.e., outcomes that were not of established interest to the research 
literature on optimism and health more widely). Supplemental Online Table 2 lists the outcome 
measures obtained for each of the studies in the analyses. 
When requesting covariates for the re-analyses, consortium participants were asked to use 
the same set of covariates that was used in the published paper. Some of the studies had an 
extraordinarily large number of covariates. Consequently, the number of covariates requested for 
inclusion in the re-analyses was capped at 20. Major classes of covariates included demographic 
variables (e.g., gender, education level), psychosocial variables (e.g., depressive symptoms, 
negative affectivity), or factors related to the study design (e.g., length of follow up from 
baseline to final assessment).  
Several categories of covariates were explicitly excluded from the re-analyses. These 
included measures of coping styles and strategies, social support, situational expectations for the 
health context studied, biomarkers and preclinical indicators of disease (e.g., C-reactive protein 
and body mass index, respectively), and health behaviors (e.g., smoking, physical activity). 
These classes of covariates were excluded because existing data has shown that these variables 
are predicted by optimism (for a review, see Scheier & Carver, 2018). Because of this 
covariation, these variables could reflect underlying mechanisms whereby the impact of 
optimism on downstream health outcomes is mediated. Correcting for potential mediators could 
artificially reduce the effect size estimating the association between optimism and health by 
eliminating the contribution of indirect pathways (Gallo & Matthews, 2003). For this reason, 
potential mediators were excluded as covariates when re-analyses were conducted. The 
covariates included for each of the studies in the analyses can also be found in Supplemental 
Online Table 2.  
 When possible, consortium members were asked to re-analyze their data in the same way 
they analyzed their data in the original study. If the original study did not conduct an analysis 
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using optimism as a predictor and physical health as an outcome, consortium members were 
requested to conduct either a linear or logistic regression, depending on whether the physical 
health outcome was continuous or dichotomous. As previously noted, all of the predictors (the 
combined overall scale, the pessimism subscale, and the optimism subscale) were treated as 
continuous variables. In addition to the requested effect sizes, researchers were also asked to 
provide the internal consistency reliability for the overall/combined optimism scale, the 
pessimism subscale, and the optimism subscale, as well as the correlation between the optimism 
and pessimism subscales. 
 Abstracted data. In addition to effect size data, pertinent data from the original 
manuscript and from the requested re-analysis were abstracted. Abstracted data included year 
study was published, scale used to assess optimism, information about the number of participants 
in the study, the mean age of participants, the percent of the sample that was female, the percent 
of the sample that was white, the type of sample studied (i.e., clinical or nonclinical), the country 
from which the sample was drawn, the optimism measure used, the number and type of 
covariates included (e.g., demographic, psychosocial), and the study design (e.g., prospective or 
cross-sectional). Finally, the aim of the original study was also coded to distinguish between 
original studies that were explicitly focused on both optimism and physical health (and the 
relationship between the two of them), and studies that were primarily interested either in 
optimism or in physical health (but not explicitly with the association between the two).  
For the purpose of this analysis, studies were coded as being prospective in design if they 
met one of the following two conditions: (1) the requested re-analyses controlled for the physical 
health outcome at baseline; (2) the study examined either mortality or disease incidence and 
screened out all participants with prior or current illness such that the sample was assumed to be 
physically healthy at baseline. Longitudinal studies were those that assessed optimism/pessimism 
measures at baseline and then documented health outcomes at a later point in time. Unlike 
prospective studies, however, health outcomes were not controlled for in some fashion at 
baseline. Cross-sectional studies were those that assessed predictor and outcome at the same 
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point in time. These distinctions are consistent with the description of study design differences 
presented by Cohen et al. (1986). 
Abstracted data were double-entered. Discrepancies in coding were resolved through 
discussion of the coders. Coder reliability across entries averaged 84%, ranging from 52% to 
99%, with the most disagreement occurring for the coding of study design.  
Statistical Analyses 
General considerations. Before the questions of primary interest could be answered, the 
data from the different samples needed to be harmonized, aggregated, and summarized. The 
analytic approach is based on methods used in meta-analysis for combining information from 
similar studies.  Random effects models (which assume that samples are drawn from different 
populations and allow for both random variance and variance due to true population differences) 
were used for all analyses conducted. Given the different contexts represented across studies, 
random effects models were assumed to provide a more accurate estimate of confidence intervals 
than fixed effects models (see e.g., Schmidt, Oh, & Hayes, 2009).  
Calculation of effect sizes. For outcomes that were treated as continuous variables, 
consortium members provided standardized beta coefficients from their analyses. For 
dichotomized outcomes, consortium members provided odds ratios or hazard ratios, depending 
upon the specific analysis conducted. The data received were than transformed into Fisher Z (Z’) 
scores, following the guidelines offered by Borenstein, Hedges, Higgins, and Rothstein (2009). 
These converted Z’ scores were then used in the meta-analytic analyses that were conducted, as 
well as in tables and figures that are presented. Z’ estimates were transformed into r estimates for 
purposes of data presentation in text.  
Heterogeneity. Heterogeneity of the variances in the effect sizes from the primary analyses 
were evaluated using the I2 index, which is an indicator of the proportion of variance explained 
by heterogeneity. An I2 index above 50% suggest a heterogeneous effect size distribution, which 
warrants additional moderator analyses (Higgins & Thompson, 2002). 
Analytic strategy. Multiple outcomes within a study were treated as dependent, as the 
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outcomes assessed were likely to be correlated to a greater or lesser extent. Therefore, the robust 
variance estimation (RVE) method was used to account for dependency among samples with 
multiple effect sizes because it allows one to specify the within-study correlation among effects. 
We utilized the default within-study correlation value of .80 in our analyses. Further, the small 
sample adjustment was applied to correct for bias in p-values (Tanner-Smith, Tipton & Polanin, 
2016).  
Importantly, more traditional meta-analytic techniques were used to compute estimates for 
which the empirically calculated degrees of freedom fell below four. For these estimates, an 
average effect size for that study was computed and used in the relevant analysis. This strategy 
was selected given that the estimated p-values can be inaccurate when the empirically calculated 
degrees of freedom fall below four (Tanner-Smith, Tipton & Polanin, 2016). 
For the RVE analyses, we tested the basic meta-regression model to estimate the mean 
effect size (i.e., intercept only, no predictors). Subsequently, moderator analyses were conducted 
by adding the respective moderator variable as a predictor to the meta-regression model. For 
continuous moderators, the coefficients can be interpreted as the estimated amount of change in 
strength of the association (i.e., mean effect size) given a one unit increase in the moderator. For 
categorical moderators, dummy codes were used and can be interpreted as the mean effect size 
difference between the relevant groups. 
Prior to analyses, the following two sets of variables were identified as potential 
moderators, depending upon whether the variable was categorical or continuous in nature. 
Continuous moderators included year the study was published, average age of sample, percent of 
sample that was female, percent of sample that was white, number of psychosocial covariates 
used in the analyses, and total number of covariates included in the analyses. Categorical 
moderators included study objective (whether the focus of the study was on optimism, physical 
health, or both), study design (whether the study was cross-sectional, longitudinal, or 
prospective), participant status (healthy versus patient), scale used to assess optimism (LOT 
versus LOT-R), and the country of origin for the study (United States versus elsewhere). 
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Finally, analyses were conducted to test for differences between optimism and pessimism. 
Preliminary analyses of the effect sizes for the pessimism and optimism subscales showed both 
distributions to be non-normal. As a result, a Wilcoxon signed rank test for paired samples was 
used to test the significance of the difference between the two subscales. For these comparisons, 
an average effect size for each study within each subscale was computed and used in the relevant 
analysis. Average ES’s were used inasmuch as Robumeta does not provide ES estimates for 
individual studies.  
Software. The RVE analyses were conducted in R (version 3.5.1) using Robumeta package 
(Fisher & Tipton, 2014) to estimate mean effect sizes and meta-regression models and 
clubSandwich package (Pustejovsky, 2015) to estimate the multiparameter F-tests. The standard 
meta-analysis estimates were obtained using Comprehensive Meta-Analysis Software Version 3 
(BiostatTM, USA). Finally, all non-meta-analytic analyses were conducted using IBM SPSS 
Statistics Version 25. 
Results 
Study Characteristics 
The number of participants in the studies reported here totaled 221,133. The participants 
averaged 63.71 years of age, were 91.44 percent female, and were 92.07 percent white (based on 
the 35 studies that reported the race of the participants). The majority of the studies were 
conducted in the United States, 90.12 percent. The high percentage of white women can be 
attributed largely to two studies, Kim et al. (2016) and Tindle et al. (2009), which were all 
women and largely white and contributed 167,274 to the participant count. 
Cronbach’s alpha for the overall/combined scale, the optimism subscale, and the pessimism 
subscale were 0.75, 0.72, and 0.75, respectively. A one-way repeated measures ANOVA was 
conducted to evaluate the significance of the differences between the alphas. This overall 
analysis was not significant, Wilk’s Lambda = .904, F (2, 54) = 2.88, p > .06 (not all of the 
researchers provided alphas, which accounts for the fewer than 59 degrees of freedom). Because 
the significance level from this overall analysis approached significance, it was followed by pair-
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wise comparisons using Bonferroni adjustments. None of the pair-wise comparisons was 
statistically significant, all p’s > .08.  Thus, differences in the reliabilities of the three measures 
were unlikely to have caused any observed differences in effect size. The correlation between the 
pessimism subscale (with items reverse coded) and the optimism subscale was .33, p < .02. The 
standard deviation of the correlation between the scales was .20. 
Primary Analyses 
Primary analyses involved evaluating effect size estimates using all outcomes from all 
studies (see Row 1 of Table 1). The effect size for the overall/combined scale was significant (k 
= 61, n = 201, r = .026, 95%CI [.013 - .039], p < .001), as were the effect sizes for the pessimism 
subscale (k = 61, n = 201, r = .029, 95%CI [.018 - .041], p < .001) and the optimism subscale (k 
= 61, n = 201, r = .011, 95%CI [.002 - .019], p < .034).  Optimism, as assessed via the 
overall/combined scale or the optimism subscale, and the absence of pessimism, as assessed by 
pessimism subscale, were all associated with better physical health. It is also clear, however, that 
the effect size associated with the pessimism subscale was considerably larger than the effect 
size associated with optimism subscale, just under 3 times as large. This difference in the 
magnitude of the effect sizes was statistically significant (Z = -2.403, p < .02). Thus, the absence 
of pessimism was a significantly better predictor of physical health than was the presence of 
optimism. Forest plots containing individual study effect sizes categorized according the manner 
in which optimism and pessimism was assessed can be found in Figure 2 (overall/combined 
scale), Figure 3 (pessimism subscale), and Figure 4 (optimism subscale). 
Stratification by Outcome 
In addition to the overall analyses, several subsidiary analyses were conducted. These 
analyses grouped outcomes a priori into several different categories, including biomarkers, 
disease prevalence/incidence/progression, survival/mortality, hospital stay or re-occurrence, 
cardiac-related, metabolic, immune function, pulmonary, and pregnancy/fertility. These 
categories were not mutually exclusive (e.g., systolic blood pressure was coded as both a 
biomarker and as cardiac-related). Additional groupings were identified, but not analyzed 
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because they contained less than 6 studies per group. The findings relevant to the outcomes 
examined can be found in the lower portion of Table 1. 
These subgroup analyses generally paralleled the findings obtained for the primary 
analyses. The effect sizes associated with the pessimism subscale tended to be larger and were 
more likely to be significant than those associated with the optimism subscale. The effect sizes 
and significance levels of the overall/combined scale fell in between the two subscales. More 
specifically, except for outcomes dealing with disease prevalence/incidence/progression, 
survival/mortality, hospital stay/readmittance, and those that were cardiac-related, the effect 
sizes for the overall/combined scale were significantly different from zero. With respect to the 
optimism subscale, 6 effect sizes were not significantly different from zero: biomarkers, disease 
prevalence/incidence/progression, hospital stay/readmittance, cardiac-related, metabolic, and 
pulmonary. In contrast, only 1 of the 9 effect sizes (hospital stay/readmittance) was not 
significantly different from zero for the pessimism subscale. For three sets of outcomes 
(biomarkers, immune function, and pregnancy) the difference in magnitude of the effect sizes for 
the optimism and pessimism subscales was statistically significant (Z = -2.987, p < .003, Z = -
2.293, p < .022, and Z = -2.028, p < .043, respectively). For all of these subsets, the absence of 
pessimism was a stronger predictor of specific health outcomes than was the presence of 
optimism.1 
Sensitivity 
In order to determine if effect size estimates were driven by a single study, “leave-one-out” 
analyses were conducted to determine how the significance level of the aggregated effect sizes 
would change as each study in turn was removed from the analysis (Greenhouse & Iyengar, 
2009). For the primary analyses, the reported effect sizes for the overall/combined scale and the 
pessimism subscale were not dependent upon any single study or studies. Each study in the 
analysis could be removed one by one and the effect size estimate still remained significant. The 
reported effect size for the optimism subscale, however, was rendered statistically insignificant 
when 1 of 2 separate studies were removed (Price et al., 2016; Sutin, 2013).  
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Leave-one-out analyses were also conducted for the subgroup analyses. The removal of one 
study did sometimes make the effect size become nonsignificant, and this happened more 
frequently for subgroup analyses involving the optimism subscale (rather than the 
overall/combined scale and the pessimism subscale). These differences among the predictors are 
not surprising, inasmuch as the effects for the optimism subscale were often weaker to start with. 
Predictably, subgroup analyses that contained fewer studies were also more vulnerable to leave-
one-out analyses. More details on sensitivity are presented in Supplemental Online Table 3. 
Moderator Analyses 
In the primary analyses, the amount of heterogeneity of variance associated with the effect 
sizes for the overall/combined scale and the pessimism subscale were quite large (I2 = 62.62% 
and I2 = 60.20%, respectively). The heterogeneity of variance in the effect sizes for the optimism 
subscale was considerably smaller (I2 = 27.02%). Although the I2 for the optimism subscale was 
below the suggested cut point identified by Higgins and Thompson (2002), moderator analyses 
were also conducted on the optimism subscale—both in order to be consistent across measures 
and because a set of potential moderator variables had been identified a priori. 
The following moderators were evaluated: year published, study objective, study design, 
participant status, age, percent of sample that was female, percent of sample that was white, the 
country of origin for the study, scale used, the number of psychosocial covariates used in the 
analyses, and total number of covariates included in the analyses. No statistically significant 
moderator effects emerged for any of the three predictors used.  
Publication Bias 
Guidelines proposed by Rothstein, Sutton, and Borenstein (2005) were used to examine for 
the presence and magnitude of publication bias. First, as previously noted, sensitivity analyses 
were performed to see if obtained effects were dependent on one or two outlying studies. These 
sensitivity analyses for the primary analyses revealed two studies that, when removed, caused the 
effect size for the optimism scale to become nonsignificant. The effect sizes for the 
overall/combined scale and the pessimism subscale were not dependent upon any one study.2 
  Optimism, Pessimism, and Health 
 18 
Next, funnel plots for the overall/combined scale, the pessimism subscale, and the optimism 
subscale from the primary analyses were inspected for bias (see Supplemental Online Figure 1, 
Supplemental Online Figure 2, and Supplemental Online Figure 3, respectively). For all the 
plots, studies with larger standard errors and larger effect sizes were clustered at the bottom of 
the plot, less so for the optimism subscale.  
Rank correlation and regression procedures were also used to evaluate publication bias. 
Kendall’s Tau (corrected for continuity) was nonsignificant for the overall/combined scale and 
each of the two subscales (all p’s > .55). Egger’s regression was significant for the overall scale 
(Intercept = .47, SE = .21, p < .04) and for the pessimism subscale (Intercept = .53, SE = .20, p < 
.02), but not for the optimism subscale (Intercept = .11, SE = .13, p > .40). Taken together, these 
general set of findings suggested that some publication bias did exist. 
Given the evidence for publication bias, Duval and Tweedie’s (2000) trim-and-fill 
procedure was used to provide a bias-corrected effect size estimate. Use of this procedure left the 
primary analyses essentially unchanged. Effects that were significant before correction for bias 
remained significant after correction. The magnitude of the effects sizes was also similar. More 
detailed data on publication bias for the overall analyses (as well as the stratified analyses by 
outcome) can be found in Supplemental Online Table 3. 
Discussion 
The results of the present reanalyses confirm the findings from earlier quantitative and 
qualitative reviews. The presence of optimism combined with the absence of pessimism (as 
assessed by the overall/combined scale) is a reliable predictor of physical health. This was true 
for an analysis that pooled all of the outcomes together and also true for the majority of analyses 
that examined subgroups of outcomes separately. This replication of prior findings is noteworthy 
inasmuch as over 80 percent of the studies included in the present reanalyses were not included 
in the previous meta-analysis (Rasmussen et al., 2009). 
The novel findings concern the relative strength of optimism and pessimism in contributing 
to associations with health. Although each was a significant predictor of physical health, the 
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effect sizes associated with the absence of pessimism were generally greater in size than those 
associated with the presence of optimism. The magnitude of these differences was great enough 
to be significantly different for the analysis aggregating across outcomes, as well as for several 
of the analyses that investigated subgroups of outcomes separately. Adjustment of the findings 
for publication bias did little to alter the basic nature of the primary findings. 
Moderator analyses were conducted on the effect sizes from the overall/combined scale, as 
well as the two subscales. These analyses failed to identify any significant moderator. It is of 
interest that there were no significant differences in effect sizes as a function of the type of study 
employed. Cross-sectional studies are open to a number of methodological criticisms, most 
notably the issue of reverse causality. Longitudinal studies examine associations across time, but 
without provisions for equating the health of participants at baseline. As such, longitudinal 
studies are subject to many of the same criticisms as are cross-sectional studies. Prospective 
studies provide the gold standard, in that they offer an assessment of the change in the outcome 
variable overtime (or otherwise start with participants who can be assumed to be equivalent in 
health at baseline). Given these considerations, it is especially striking that the moderator 
analyses revealed that study design did not significantly impact the magnitude of the effect sizes 
that were obtained.  
The foregoing discussion speaks to the statistical reliability of the effects that emerged. A 
few words also need to be said about the magnitude of the effects that emerged. The effects sizes 
reported here appear small. Several considerations should be borne in mind, however, when 
evaluating the effect sizes obtained. First, as just noted, the effect sizes reported are adjusted for 
a host of factors, including those related to demographics, study design, and other confounding 
psychosocial factors. Thus, the effect sizes reported are unique to optimism and pessimism. It is 
not surprising that the effect sizes are somewhat small, especially so inasmuch as shared variance 
with related psychosocial factors had been removed. 
The second point to make is that statistical effects, even small ones, can be quite 
meaningful when applied to large numbers of people. Take for example, the effect size 
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characterizing the association between the pessimism subscale and mortality. The corresponding 
adjusted odds ratio for this effect in the present reanalysis is 1.074 [95% CI (1.024, 1.126)]. In 
terms of the number of people who lived and died in the United States in 2016 (the year the most 
recent study in these reanalyses was published), this odds ratio implies that a 1-point change in 
the pessimism direction of the pessimism subscale corresponds to an increase in  97,914 deaths 
from all causes [95% CI (32,540, 162,641)].  
Finally, it is worth mentioning that the size of the effects obtained using the present meta-
analytic techniques are quite comparable to effects reported in other meta-analyses of 
psychosocial factors and physical health when the studies are put on this same metric [see, e.g., 
Richardson et al. (2012) for a meta-analysis of perceived stress and incident coronary heart 
disease and Kivimäki et al., 2012 for a meta-analysis of job strain and coronary heart disease]. 
Taken together, these considerations suggest that from a public health standpoint the magnitude 
of the effects obtained in the present analysis are nontrivial and quite comparable to other 
findings in the literature. 
The present set of reanalyses has several potential limitations that should be highlighted. 
First, search terms for the present analysis relied heavily on the framework used by Rasmussen et 
al. (2009). The scheme used here is only one of many that could be adopted. Different search 
terms could yield a different corpus of studies, and the findings obtained using those different 
studies could be somewhat different. 
Second, the yield rate for relevant studies was 32%. It is difficult to evaluate this yield rate 
compared to other meta-analytic studies. This is the case because the data required for the 
present study could not be extracted from published studies. Rather, the analysis was contingent 
on authors of those published studies reanalyzing their data and forwarding on the results of 
those re-analyses. It is likely that this extra requirement lowered the yield rate to some extent. 
The third limitation concerns the homogeneous nature of the gender and racial composition 
of the participants. Although these factors differed somewhat from study to study, over 90% of 
the overall sample were white and women. Additionally, over 90% of the studies were conducted 
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in the United States. More studies are clearly needed to determine if the effects reported here are 
replicable in more diverse populations.  
Fourth, the conduct of the present research was a group effort. The analyses could not have 
been done if consortium members had not conducted the needed analyses and forwarded their 
findings to the primary authors for further meta-analytic processing. On the positive side, the 
project represents one of the best examples of collaborative science in the truest sense of the 
term. On the negative side, the more people involved, the more potential there is for error. This 
concern is mitigated by the fact that the researchers involved had already published peer 
reviewed papers with these same data, and as such had already demonstrated significant 
capability with these analyses. 
Finally, the outcomes examined in the present study all involved physical health. It is 
unclear if similar findings would obtain if mental health outcomes were examined. Perhaps 
optimism and pessimism would be equally robust as predictors of psychological well-being. 
Perhaps optimism would be stronger. It is important not to extrapolate the findings obtained with 
the present set of outcomes to possible findings involving other outcomes. Future research on 
psychological well-being should report results for the optimism and pessimism subscales 
separately, in order to evaluate the relative strength of the two dimensions in predicting 
outcomes in that domain. 
There is a more nuanced point to be made here than simply to acknowledge that the 
differential impact of optimism and pessimism on psychological well-being needs to be 
explored. That is, stress has been identified as one potentially important factor that might 
mediate the impact of optimism (and pessimism) on physical health (Scheier & Carver, 2018). 
How? The idea is that stress (and stress-related emotions) might modulate downstream biological 
systems that underlie health and disease.  
Optimists cope with and psychologically react to adversity in a different way than do 
pessimists (Segerstrom et al., 2017). It would be interesting to see within this context if the 
presence or absence of optimism and the presence or absence of pessimism relate differentially 
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to the various emotions that arise in reaction to stressful circumstances. It would further be 
interesting to see if these potentially different emotions (that characterize the reactions of 
optimists and pessimists to stress) might themselves be more or less strongly related to physical 
health outcomes. Answering questions such as these could further in a significant way our 
understanding of why it might be that the absence of pessimism is more strongly related to 
physical health outcomes than is the presence of optimism. 
Limitations aside, the present findings have at least three implications. First, future research 
should, as a matter of course, provide effect size information for the overall/combined scale and 
the two subscales separately—a suggestion that has been made previously (Scheier et al., 1994). 
Such a practice is even more important now that quantitative data exist documenting the 
differential associations of the two subscales with physical health. With the complete 
complement of effect sizes reported, future research could continue to evaluate the importance of 
the separate contributions of optimism versus pessimism without the need to establish 
consortiums. 
The present findings also hold important implications for positive psychology (Peterson & 
Park, 2003; Seligman & Csikszentmihalyi, 2000). Positive psychology emphasizes those 
characteristics that enable people to experience full, industrious, and resilient lives. As such, it 
stands in contrast to traditional views that tend to focus on negative attributes, such as 
depression, anxiety, and other characteristics which undermine successful living.  Dispositional 
optimism is often described as a good example of a variable falling within the positive 
psychology domain (e.g., Dunn, 2018). As the present data make clear, however, the presence of 
optimism does not provide the whole story. Optimism is important, but it does not appear to be 
as important as the absence of pessimism in predicting physical health.  
In the future, researchers in positive psychology might benefit from taking these findings 
into account when planning and conducting research. Researchers should examine more closely 
the predictor variables they are using to see if negative and positive characteristics might be 
intermingled in the measures employed. If so, an effort should be made to tease apart the positive 
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and negative components of the measures to determine what is in fact responsible for doing the 
predicting. Ultimately, it may turn out that it is the positive aspects of the measures that are 
important, but it also possible that the negative features are the ones driving the observed 
associations. Only by explicitly evaluating these possibilities will we know for sure.  
The final implication concerns interventions. Future efforts to design and adapt 
interventions to promote better health should keep in mind the differential links between 
optimism, pessimism, and physical health. In this regard, it is interesting that some cognitive 
behavior therapies seem to put a greater emphasis on lessening pessimism than they do on 
promoting optimism. One example of such an intervention concerns cognitive restructuring 
(Leahy & Rego, 2012), in which participants are trained to challenge the automatic thoughts, 
beliefs, and expectancies underlying negative feelings. Participants confront their automatic, 
negative thinking by systematically, and explicitly monitoring their moods and assessing in a 
more objective fashion the information in the ongoing context that either supports or challenges 
their negative thoughts. Perhaps existing interventions that focus more on lessening pessimism 
such as those involving cognitive restructuring will be more successful in promoting better 
health than will those that place a greater weight on promoting optimism, or even those that 
place an equal weight on both components. Note that it is not a matter of causing harm, but more 
a matter of targeting the component that offers the most gain. 
It is also possible, however, that things are more complicated. Perhaps what works best will 
depend on the nature of the outcome of interest (e.g., health behaviors versus biological 
pathways). Intervention efforts with respect to optimism, pessimism, and physical health are still 
in their infancy. As research in the intervention domain continues to evolve, it would seem 
prudent to keep the distinction between optimism and pessimism in mind. Doing so may prove 
profitable both practically and theoretically. 
References 
References preceded by an asterisk indicates studies included in the meta-analysis. 
*Abdou, C. M., Schetter, C. D., Campos, B., Hilmert, C. J., Dominguez, T. P., Hobel, C. J., 
  Optimism, Pessimism, and Health 
 24 
Glynn, L. M., & Sandman, C. (2010). Communalism predicts prenatal affect, stress, and 
physiology better than ethnicity and socioeconomic status. Cultural Diversity and Ethnic 
Minority Psychology, 16(3), 395-403. doi.org/10.1037/a0019808 
*Anthony, E. G., Kritz-Silverstein, D., & Barrett-Connor, E. (2016). Optimism and mortality in 
older men and women: The Rancho Bernardo Study. Journal of Aging Research, 
2016(5185104). doi.org/10.1155/2016/5185104 
Assad, K. K. et al. (2007) Optimism: An enduring resource for romantic relationships. Journal of 
Personality and Social Psychology, 93, 285-297. doi:10.1037/0022-3514.93.2.285 
Bates, T. C. (2015). The glass is half full and half empty: A population-representative twin study 
testing if optimism and pessimism are distinct systems. The Journal of Positive 
Psychology, 10, 533-542. doi:10.1080/17439760.2015.1015155 
*Beckie, T. M., Fletcher, G., Groer, M. W., Kip, K. E., & Ji, M. (2015). Biopsychosocial health 
disparities among young women enrolled in cardiac rehabilitation. Journal of 
Cardiopulmonary Rehabilitation and Prevention, 35(2), 102-113. 
doi:10.1097/HCR.0000000000000095 
*Ben-Zur, H., Rappaport, B., & Uretzky, G. (2004). Pessimism, lifestyle, and survival: A follow-
up study of open-heart surgery patients in Israel. Illness, Crisis & Loss, 12(4), 299-306. 
doi.org/10.1177/1054137304268337 
*Bennett, D. S., Snooks, Q., Llera, S., Vogel, K., Conklin, D., & Varlotta, L. (2008). Monitoring 
and internalizing symptoms among youths with cystic fibrosis. Children’s Health Care, 
37(4), 278-293. doi.org/10.1080/02739610802437426 
Bennett, P. N., Parsons, T., Ben-Moshe, R., Neal, M., Weinberg, M. K., Glibert, K., Ockerby, C., 
Rawson, H., Herbu, C., & Hutchinson, A. M. (2015). Intradialytic laughter yoga therapy 
for haemodialysis patients: A pre-post intervention feasibility study. BMC Complementary 
and Alternative Medicine, 15, 176. doi.org/10.1186/s12906-015-0705-5 
*Bleil, M. E., Pasch, L. A., Gregorich, S. E., Millstein, S. G., Katz, P. P., & Alder, N. E. (2012). 
Fertility treatment response: Is it better to be more optimistic or less pessimistic? 
  Optimism, Pessimism, and Health 
 25 
Psychosomatic Medicine, 74(2), 193-199. doi:10.1097/PSY.0b013e318242096b 
Boehm, J. K., & Kubzansky, L. D. (2012). The heart’s content: The association between positive 
psychological well-being and cardiovascular health. Psychological Bulletin, 138, 655-691. 
doi:10.1037/a0027448 
Boehm, J. K., Williams, D. R., Rimm, E. B., Ryff, C., & Kubzansky, L. D. (2013a). Relation 
between optimism and lipids in midlife. The American Journal of Cardiology, 111(10), 
1425-1431. doi:10.1016/j.amjcard.2013.01.292 
*Boehm, J. K., Williams, D. R., Rimm, E. B., Ryff, C., & Kubzansky, L. D. (2013b). 
Association between optimism and serum antioxidants in the Midlife in the United States 
Study. Psychosomatic Medicine, 75(1), 2-10. doi:10.1097/PSY.0b013e31827c08a9 
Borenstein, M., Hedges, L. V., Higgins, J. P. T., & Rothstein, H. R. (2009). Introduction to meta-
analsis. New York: Wiley. 
*Boylan, J. M., Jennings, J. R., & Matthews, K. A. (2016). Childhood socioeconomic status and 
cardiovascular reactivity and recovery among black and white men: Mitigating effects of 
psychological resources. Health Psychology, 35(9), 957-966. doi.org/10.1037/hea0000355 
Caprara, G. V., Fagnani, C., Alessandri, G., Steca, P., Gigantesco, A., Sforza, L. L. C., & Stazi, 
M. A. (2009). Human optimal functioning: The genetics of positive orientation towards 
self, life, and the future. Behavior Genetics, 39, 277-284. 
Carver, C. S. & Scheier, M. F. (2019). Optimism. In M. W. Gallagher & S. J. Lopez 
(Eds.), Positive psychological assessment: A handbook of models and measures (2nd ed, 
pp. 61-76). Washington, DC: American Psychological Association. 
*Catov, J. M., Abatemarco, D. J., Markovic, N., & Roberts, J. M. (2010). Anxiety and optimism 
associated with gestational age at birth and fetal growth. Maternal Health Journal, 14(5), 
758-764. doi:10.1007/s10995-009-0513-y 
*Catov, J. M., Flint, M., Lee, M., Roberts, J. M., & Abatemarco, D. J. (2015). The relationship 
between race, inflammation and psychosocial factors among pregnant women. Maternal 
Health Journal, 19(2), 401-409. doi:10.1007/s10995-014-1522-z 
  Optimism, Pessimism, and Health 
 26 
*Celano, C. M., Beale, E. E., Beach, S. R., Belcher, A. M., Suarez, L., Motiwala, S. R., Gandhi, 
P. U., Gaggin, H., Januzzi, J. L., Healy, B. C., & Huffman, J. C. (2016). Associations 
between psychological constructs and cardiac biomarkers after Acute Coronary Syndrome. 
Psychosomatic Medicine, 79(3), 318-326. doi:10.1097/PSY.0000000000000404 
Chang, L., & McBride-Chang, C. (1996). The factor structure of the Life Orientation Test. 
Educational and Psychological Measurement, 56(2), 325-329. 
doi.org/10.1177/0013164496056002013 
*Cohen, S., Alper, C. M., Doyle, W. J., Treanor, J. J., & Turner, R. B. (2006). Positive emotional 
style predicts resistance to illness after experimental exposure to Rhinovirus or Influenza A 
Virus. Psychosomatic Medicine, 68(6), 809-815. doi:10.1097/01.psy.0000245867.92364.3c 
Cohen S., Evans G. W., Stokols D., Krantz, D. S. (1986). Behavior, health, and environmental 
stress. New York: Plenum. 
*Contrada, R. J., Goyal, T. M., Cather, C., Rafalson, L., Idler, E. L., & Krause, T. J. (2004). 
Psychosocial factors in outcomes of heart surgery: The impact of religious involvement and 
depressive symptoms. Health Psychology, 23(3), 227-238. doi:10.1037/0278-
6133.23.3.227 
*Contrada, R. J., Boulifard, D. A., Hekler, E. B., Idler, E. L., Labouvie, E. W., Spruill, T. M., & 
Krause, T. J. (2008). Psychosocial factors in heart surgery: Presurgical vulnerability and 
postsurgical recovery. Health Psychology, 27(3), 309-319. doi:10.1037/0278-
6133.27.3.309 
Duffy R.D. et al. (2013) Examining a model of life satisfaction among unemployed adults. 
Journal of Counseling Psychology, 60, 53–63. doi:10.1037/a0030771 
*Dumitrescu, A. L., & Kawamura, M. (2010). Involvement of psychosocial factors in the 
association of obesity with periodontitis. Journal of Oral Science, 55(1), 115-124. 
doi.org/10.2334/josnusd.52.115 
Dunn, D. S. (Ed.) (2018). Positive psychology: Established and emerging issues. New York, NY: 
Routledge. 
  Optimism, Pessimism, and Health 
 27 
Duval, S., & Tweedie, R. (2000). Trim and fill: A simple funnel‐plot–based method of testing 
and adjusting for publication bias in meta‐analysis. Biometrics, 56(2), 455-463. 
doi.org/10.1111/j.0006-341X.2000.00455.x 
*Elavsky, S., & McAuley, E. (2009). Personality, menopausal symptoms, and physical activity 
outcomes in middle-aged women. Personality and Individual Differences, 46(2), 123-128. 
doi:10.1016/j.paid.2008.09.014 
*Elliot, A. J., & Chapman, B. P. (2016). Socioeconomic status, psychological resources, and 
inflammatory markers: Results from the MIDUS Study. Health Psychology, 35(11), 1205-
1213. doi:10.1037/hea0000392 
*Endrighi, R., Hamer, M., & Steptoe, A. (2011). Associations of trait optimism with diurnal 
neuroendocrine activity, cortisol responses to mental stress, and subjective stress measures 
in healthy men and women. Psychosomatic Medicine, 73, 672-678. 
doi:10.1097/PSY.0b013e31822f9cd7 
Fisher, Z., & Tipton, E. (2014). Robumeta: Robust variance meta-regression. Available at: 
http://cran.rproject.org/web/packages/robumeta/index.html. 
*Frain, M. P., Berven, N. L., Chan, F., & Tschopp, M. K. (2008). Family resiliency, uncertainty, 
optimism, and the quality of life of individuals with HIV/AIDS. Rehabilitation Counseling 
Bulletin, 52(1), 16-27. doi.org/10.1177/0034355208316344 
Gallo, L. C., & Matthews, K. A. (2003). Understanding the association between socioeconomic 
status and physical health: Do negative emotions play a role? Psychological Bulletin, 129, 
10-51. doi.org/10.1037/0033-2909.129.1.10 
Greenhouse, J. B., & Iyengar, S. (2009). Sensitivity analysis and diagnostics. In H. Cooper, L. V. 
Hedges, & Valentine, J. C. (Eds.), Handbook of research synthesis and meta-analysis (2nd 
ed, pp. 417-434). New York: The Russell Sage Foundation. 
Hjelle, L., Belongia, C., & Nesser, J. (1996). Psychometric properties of the Life Orientation 
Test and Attributional Style Questionnaire. Psychological Reports, 78(2), 507-515. 
doi.org/10.2466/pr0.1996.78.2.507 
  Optimism, Pessimism, and Health 
 28 
*Huffman, J. C., Moore, S. V., DuBois, C. M., Mastromauro, C. A., Suarez, L., & Park, E. R. 
(2015). An exploratory mixed methods analysis of adherence predictors following acute 
coronary syndrome. Psychology, Health, & Medicine, 20(5), 541-550. 
doi:10.1080/13548506.2014.989531 
*Ikeda, A., Schwartz, J., Peters, J. L., Fang, S., Spiro, A., Sparrow, D., Vokonas, P., & 
Kubzansky, L. D. (2011). Optimism in relation to inflammation and endothelial 
dysfunction in older men: The VA Normative Aging Study. Psychosomatic Medicine, 
73(8), 664-671. doi:10.1097/PSY.0b013e3182312497 
*Jackowska, M., Ronaldson, A., Brown, J., & Steptoe, A. (2016). Biological and psychological 
correlates of self-reported and objective sleep measures. Journal of Psychosomatic 
Research, 84, 52-55. doi:10.1016/j.jpsychores.2016.03.017 
*Jobin, J., Wrosch, C., & Scheier, M. F. (2014). Associations between dispositional optimism 
and diurnal cortisol in a community sample: When stress is perceived as higher than 
normal. Health Psychology, 33(4), 382-391. doi:10.1037/a0032736 
*Kim, E. S., Hagan, K. A., Grodstein, F., DeMeo, D. L., De Vivo, I., & Kubzansky, L. D. 
(2016). Optimism and cause-specific mortality: A prospective cohort study. American 
Journal of Epidemiology, 185(1), 21-29. doi:10.1093/aje/kww182 
Kim, E. S., Park, N., & Peterson, C. (2011). Dispositional optimism protects older adults from 
stroke: The Health and Retirement Study. Stroke, 42(10), 2855-2859. 
doi:10.1161/STROKEAHA.111.613448 
*Kim, E. S., Smith, J., & Kubzansky, L. D. (2014). A prospective study of the association 
between dispositional optimism and incident heart failure. Circulation: Heart Failure, 7(3), 
394-400. doi:10.1161/CIRCHEARTFAILURE.113.000644 
Kivimäki, M., Nyberg, S. T., Batty, G. D., Fransson, E. I., Heikkilä, K., Alfredsson, L., . . . 
Theorell, T. (2012). Job strain as a risk factor for coronary heart disease: A collaborative 
meta-analysis of individual participant data. The Lancet, 380, 1491-1497. 
*Knight, J. M., Moynihan, J. A., Lyness, J. M., Xia, Y., Tu, X., Messing, S., Hunter, B. C., 
  Optimism, Pessimism, and Health 
 29 
Huang, L., Obi, R. O., Gaisser, D., Liesveld, J. L., & Sahler, O. J., (2014). Peri-transplant 
psychosocial factors and neutrophil recovery following hematopoietic stem cell 
transplantation. PLoS ONE, 9(6), e99778. doi:10.1371/journal.pone.0099778 
*Konkoly-Thege, B., Tarnoki, A. D., Tarnoki, D. L., Garami, Z., Berczi, V., Horvath, I., & 
Veress, G. (2015). Is flourishing good for the heart? Relationships between positive 
psychology characteristics and cardiorespiratory health. Anales De Psicología, 31(1), 55-
65. doi.org/10.6018/analesps.31.1.171471 
*Kostka, T., & Jachimowicz, V. (2010). Relationship of quality of life to dispositional optimism, 
health locus of control and self-efficacy in older subjects living in different environments. 
Quality of Life Research, 19(3), 351-361. doi:10.1007/s11136-010-9601-0 
Kubzansky, L. D., Kubzansky, P. E., & Maselko, J. (2004). Optimism and pessimism in the 
context of health: Bipolar opposites or separate constructs? Personality and Social 
Psychology Bulletin, 30(8), 943-956. doi.org/10.1177/0146167203262086 
*Lancastle, D., & Boivin, J. (2005). Dispositional optimism, trait anxiety, and coping: Unique or 
shared effects on biological response to fertility treatment? Health Psychology, 24(2), 171-
178. doi:10.1037/0278-6133.24.2.171 
*Latendresse, G., & Ruiz, R. J. (2010). Maternal coping style and perceived adequacy of income 
predict CRH levels at 14-20 weeks of gestation. Biological Research for Nursing, 12(2), 
125-136. doi:10.1177/1099800410377111 
Leahy, R. L., & Rego, S. A. (2012). Cognitive restructuring. In W. O’Donohue & J. E. Fisher 
(Eds), Cognitive behavior therapy (pp. 133-158). Hoboken, NJ: John Wiley & Sons. 
Lemola, S., Räikkönen, K., Matthews, K. A., Scheier, M. F., Heinonen, K., Pesonen, A. K., 
Komsi, N., & Lahti, J. (2010).  A new measure of dispositional optimism and pessimism in 
young children.  European Journal of Personality, 24, 71-84. doi:10.1002/per.742 
*Lemola, S., Räikkönen, K., Scheier, M.F., Matthews, K.A., Pesonen, A.K., Heinonen, K., Lahti, 
J., Komsi, N., Paavonen, J.E. and Kajantie, E. (2011). Sleep quantity, quality and optimism 
in children. Journal of Sleep Research, 20, 12-20. doi:10.1111/j.1365-2869.2010.00856.x 
  Optimism, Pessimism, and Health 
 30 
*Low, C. A., Matthews, K. A., Kuller, L. H., & Edmundowicz, D. (2011). Psychosocial 
predictors of coronary artery calcification progression in postmenopausal women. 
Psychosomatic Medicine, 73(9), 789-794. doi:10.1097/PSY.0b013e318236b68a 
*McDonald, S. W., Kingston, D., Bayrampour, H., Dolan, S. M., & Tough, S. C. (2014). 
Cumulative psychosocial stress, coping resources, and preterm birth. Archives of Women’s 
Mental Health, 17(6), 559-568. doi:10.1007/s00737-014-0436- 
Mens, M. G., Scheier, M. F., & Carver, C. S. (2016). Optimism. In S. Lopez, L. M. Edwards, & 
S. C. Marques (Eds.), The Oxford handbook of positive psychology (3rd edition).  New 
York, NY: Oxford University Press. doi:10.1093/oxfordhb/9780199396511.013.24 
*Milam, J. (2006). Posttraumatic growth and HIV disease progression. Journal of Consulting 
and Clinical Psychology, 74, 817-827. 
*Minton, M. E., Hertzog, M., Barron, C. R., French, J. A., Reiter-Palmon, R. (2009). The first 
anniversary: Stress, well-being, and optimism in older widows. Western Journal of Nursing 
Research, 31(8), 1035-1056. doi:10.1177/0193945909339497 
Monzani, D., Steca, P., & Greco, A. (2014). Brief report: Assessing dispositional optimism in 
adolescence—factor structure and concurrent validity of the Life Orientation Test–
Revised. Journal of Adolescence, 37(2), 97-101. doi:10.1016/j.adolescence.2013.11.006 
*Mosing, M. A., Medland, S. E., McRae, A., Landers, J. G., Wright, M. J., & Martin, N. G. 
(2012). Genetic influences on life span and its relationship to personality: A 16-year 
follow-up study of a sample of aging twins. Psychosomatic Medicine, 74(1), 16-22.  
*Moyer, C. A., Elsayed, Y., Zhu, Y., Wei, Y., Engmann, C. M., & Yang, H. (2010). Is 
generalized maternal optimism or pessimism during pregnancy associated with unplanned 
Cesarean Section deliveries in China? Journal of Pregnancy, Article ID 754938. 
doi.org/10.1155/2010/754938 
*O’Donovan, A. O., Lin, J., Dhabhar, F. S., Wolkowitz, O., Tillie, J. M., Blackburn, E., Epel, E. 
(2009). Pessimism correlates with leukocyte telomere shortness and elevated Interleukin-6 
in post-menopausal women. Brain, Behavior, and Immunity, 23(4), 446-449. 
  Optimism, Pessimism, and Health 
 31 
doi:10.1016/j.bbi.2008.11.006 
*Oliver, K. N., Free, M. L., Bok, C., McCoy, K. S., Lemanek, K. L., & Emery, C. F. (2014). 
Stigma and optimism in adolescents and young adults with cystic fibrosis. Journal of 
Cystic Fibrosis, 13(6), 737-744. doi.org/10.1016/j.jcf.2014.04.005 
*Pänkäläinen, M. T., Kerola, T. V., & Hintikka, J. J. (2015). Pessimism and the risk for coronary 
heart disease among middle-aged and older Finnish men and women: A ten-year follow-up 
study. BMC Cardiovascular Disorders, 15(113). doi.org/10.1186/s12872-015-0097-y 
*Pänkäläinen, M. T., Kerola, T. V., Kampman, O., Kauppi, M., & Hintikka, J. J. (2016). 
Pessimism and risk of death from coronary heart disease among middle-aged and older 
Finns: An eleven-year follow-up study. BMC Public Health, 16(1), 1124. 
doi.org/10.1186/s12889-016-3764-8 
*Peters, M. L., Sommer, M., van Kleef, M., Marcus, M. A. E. (2010). Predictors of physical and 
emotional recovery 6 and 12 months after surgery. British Journal of Surgery, 97(10), 
1518-1527. doi:10.1002/bjs.7152 
Peterson, C., & Park, N. (2003). Positive psychology as the evenhanded positive psychologist 
views it. Psychological Inquiry, 14, 143-147. 
*Petros, N., Opacka-Juffry, J., & Huber, J. H. (2013). Psychometric and neurobiological 
assessment of resilience in a non-clinical sample of adults. Psychoneuroendocrinology, 
38(10), 2099-2108. doi:10.1016/j.psyneuen.2013.03.022 
Plomin, R., Scheier, M. F., Bergeman, C. S., Pedersen, N. L., Nesselroade, J. R., & McClearn, G. 
E. (1992). Optimism, pessimism and mental health: A twin/adoption analysis. Personality 
and Individual Differences, 13(8), 921-930. 
*Popa-Velea, O., & Purcarea, V. L. (2014). Psychological factors mediating health-related 
quality of life in COPD. Journal of Medicine and Life, 7(1), 100-103.  
*Price, M. A., Butow, P. N., Bell, M. L., DeFazio, A., Friedlander, M., Fardell, J. E., Protani, M. 
M., & Webb, P. M. (2016). Helplessness/hopelessness, minimization and optimism predict 
survival in women with invasive ovarian cancer: A role for targeted support during initial 
  Optimism, Pessimism, and Health 
 32 
treatment decision-making? Support Care Cancer, 24(6), 2627-2634. doi:10.1007/s00520-
015-3070-5 
Pustejovsky, J. E. (2015). clubSandwich: Cluster-robust (sandwich) variance estimators with 
small sample corrections. R package version 0.0.0.9000. URL: 
https://github.com/jepusto/clubSandwich 
Rasmussen, H. N., Scheier, M. F., & Greenhouse, J. B. (2009). Optimism and physical health: A 
meta-analytic review. Annals of Behavioral Medicine, 37(3), 239-256. doi:10.1007/s12160-
009-9111-x 
Richardson, S., Shaffer, J. A., Falzon, L., Krupka, D., Davidson, K. W., & Edmondson, D. 
(2012). Meta-analysis of perceived stress and its association with incident coronary heart 
disease. American Journal of Cardiology, 110, 1711-1716. 
*Richman, L. S., Bennett, G. G., Pek, J., Siegler, I., & Williams, R. B. (2007). Discrimination, 
dispositions, and cardiovascular responses to stress. Health Psychology, 26(6), 675-683. 
doi:10.1037/0278-6133.26.6.675 
Räikkönen, K., Matthews, K. A., Flory, J. D., Owens, J. F., & Gump, B. B. (1999). Effects of 
optimism, pessimism, and trait anxiety on ambulatory blood pressure and mood during 
everyday life. Journal of Personality and Social Psychology, 76(1), 104-113. 
doi.org/10.1037/0022-3514.76.1.104 
*Rohrbaugh, M. J., Shoham, V., & Coyne, J. C. (2006). Effect of marital quality on eight-year 
survival of patients with heart failure. The American Journal of Cardiology, 98(8), 1069-
1072. doi.org/10.1016/j.amjcard.2006.05.034 
Rothstein, H., Sutton, A., & Borenstein, M. (2005). Publication bias in meta-analysis: 
Prevention, assessment and adjustments. New York: Wiley. 
Roy, B., Diez-Roux, A. V., Seeman, T., Ranjit, N., Shea, S., & Cushman, M. (2010). The 
association of optimism and pessimism with inflammation and hemostasis in the Multi-
Ethnic Study of Atherosclerosis (MESA). Psychosomatic Medicine, 72(2), 134-140. 
doi:10.1097/PSY.0b013e3181cb981b 
  Optimism, Pessimism, and Health 
 33 
*Ruis-Ottenheim, N., de Craen, A. J. M., Geleijnse, J. M., Slagboom, P. E., Kromhout, D., van 
der Mast, R. C., Zitman, F. G., Westendorp, R. G., & Giltay, E. J. (2012). C-reactive 
protein haplotypes and dispositional optimism in obese and nonobese elderly subjects. 
Inflammation Research, 61(1), 43-51. doi.org/10.1007/s00011-011-0387-5 
*Ruiz, J. M., Matthews, K. A., Scheier, M. F., Schulz, R. (2006). Does who you marry matter for 
your health? Influence of patients’ and spouses’ personality on their partners’ 
psychological well-being following coronary artery bypass surgery. Journal of Personality 
and Social Psychology, 91(2), 255-267. doi:10.1037/0022-3514.91.2.255 
*Salmoirago-Blotcher, E., Rosman, L., Wittstein, I. S., Dunsiger, S., Swales, H. H., Aurigemma, 
G. P., & Ockene, I. S. (2016). Psychiatric history, post-discharge distress, and personality 
characteristics among incident female cases of takotsubo cardiomyopathy: A case control 
study. Heart & Lung, 45(6), 503-509. doi:10.1016/j.hrtlng.2016.07.008 
*Saquib, N., Pierce, J.P., Saquib, J., Flatt, S.W., Natarajan, L., Bardwell, W.A., Patterson, R.E., 
Stefanick, M.L., Thomson, C.A., Rock, C.L. and Jones, L.A., 2011. Poor physical health 
predicts time to additional breast cancer events and mortality in breast cancer survivors. 
Psycho‐Oncology, 20(3), 252-259. doi:10.1002/pon.1742 
Scheier, M. F., & Carver, C. S. (1985). Optimism, coping, and health: Assessment and 
implications of generalized outcome expectancies. Health Psychology, 4(3), 219- 247. 
doi.org/10.1037/0278-6133.4.3.219 
Scheier, M. F., Carver, C. S., & Bridges, M. W. (1994). Distinguishing optimism from 
neuroticism (and trait anxiety, self-mastery, and self-esteem): A reevaluation of the Life 
Orientation Test. Journal of Personality and Social Psychology, 67(6), 1063-1078. 
doi.org/10.1037/0022-3514.67.6.1063 
*Scheier, M. F., Matthews, K. A., Owens, J. F., Schulz, R., Bridges, M. W., Magovern, G. J., & 
Carver, C. S. (1999). Optimism and rehospitalization after coronary artery bypass graft 
surgery. Archives of Internal Medicine, 159(8), 829-835. doi:10.1001/archinte.159.8.829 
Seligman, M. E. P., & Csikszentmihalye, M. (Guest Eds.) (2000). Positive psychology. American 
  Optimism, Pessimism, and Health 
 34 
Psychologist, 55, 5-183. 
*Serlachius A., Pulkki-Råback, L., Elovanio, M., Hintsanen M., Mikkilä, V., Laitinen, T. T., 
Jokela, M., Rosenström, T., Josefsson, K., Juonala, M., Lehtimäki, T., Raitakari, O., & 
Keltikangas-Järvinen, L. (2015). Is dispositional optimism or dispositional pessimism 
predictive of ideal cardiovascular health? The Young Finns Study. Psychology & Health, 
30(10), 1221-1239. doi:10.1080/08870446.2015.1041394 
Segerstrom, S. C., Carver, C. S., & Scheier, M. F. (2017). Optimism. In M. Eid & M. D. 
Robinson (Eds.), The happy mind: Cognitive contributions to well-being (pp. 195-212).  
New York: Springer. doi.org/10.1007/978-3-319-58763-9_11 
Steca, P., Monzani, D., Greco, A., Chiesi, F., & Primi, C. (2014). Item response theory analysis 
of the Life Orientation Test-Revised: Age and gender differential item functioning 
analyses. Assessment, 22(3), 341-350. doi.org/10.1177/1073191114544471 
*Stewart, J. C., Zielke, D. J., Hawkins, M. A. W., Williams, D. R., Carnethon, M. R., Knox, S. 
S., & Matthews, K. A. (2012). Depressive symptom clusters and 5-year incidence of 
coronary artery calcification. Circulation, 126(410), 410-417. 
doi:10.1161/CIRCULATIONAHA.112.094946 
*Sutin, A. R. (2013). Optimism, pessimism and bias in self-reported body weight among older 
adults. Obesity, 21(9), E508-E511. doi:10.1002/oby.20447 
*Tindle, H., Belnap, B. H., Hum, B., Houck, P. R., Mazumdar, S., Scheier, M. F., Matthews, K. 
A., He, F., & Rollman, B. L. (2012). Optimism, response to treatment of depression, and 
rehospitalization after coronary artery bypass graft surgery. Psychosomatic Medicine, 
74(2), 200-207. doi:10.1097/PSY.0b013e318244903f 
*Tindle, H. A., Chang, Y., Kuller, L. H., Manson, J. E., Robinson, J. G., Rosal, M. C., Siegle, G. 
J., & Matthews, K. A. (2009). Optimism, cynical hostility, and incident coronary heart 
disease and mortality in the Women’s Health Initiative. Circulation, 120(8), 656-662. 
doi:10.1161/CIRCULATIONAHA.108.827642 
*Tomakowsky, J., Lumley, M. A., Markowitz, N., & Frank, C. (2001). Optimistic explanatory 
  Optimism, Pessimism, and Health 
 35 
style and dispositional optimism in HIV-infected men. Journal of Psychosomatic Research, 
51(4), 577-587. doi.org/10.1016/S0022-3999(01)00249-5 
*Van Allen, J., Steele, R. G., Nelson, M. B., Peugh, J., Egan, A., Clements, M., & Patton, S. R. 
(2015). A longitudinal examination of hope and optimism and their role in Type 1 diabetes 
in youths. Journal of Pediatric Psychology, 41(7), 741-749. doi:10.1093/jpepsy/jsv113 
*van de Rest, O., de Goede, J., Sytsma, F., Griep, L. M. O., Geleijnse, J. M., Kromhout, D., 
&Giltay, E. J. (2010). Association of n-3 long-chain PUFA and fish intake with depressive 
symptoms and low dispositional optimism in older subjects with a history of myocardial 
infarction. British Journal of Nutrition, 103(9), 1381-1387. doi:10.3945/ajcn.111.018259 
*Yi-Frazier, J. P., Yaptangco, M., Semana, S., Buscaino, E., Thompson, V., Cochraine, K., 
Tabile, M., Alving, E., & Rosenberg, A. R. (2015). The association of personal resilience 
with stress, coping, and diabetes outcomes in adolescents with Type 1 diabetes: Variable- 
and person-focused approaches. Journal of Health Psychology, 20(9), 1196-1206. 
doi:10.1177/1359105313509846 
*Ylöstalo, P. V., Ek, E., Laitinen, J., & Knuuttila, M. L. (2003). Optimism and life satisfaction as 
determinants for dental and general health behavior—oral health habits linked to 
cardiovascular risk factors. Journal of Dental Research, 82(3), 194-199. 
doi:10.1177/154405910308200309 
  
  Optimism, Pessimism, and Health 
 36 
Footnotes 
1 As Table 1 shows, RVE could only be used for some of the analyses conducted because 
of constraints on degrees of freedom. As a supplement to these RVE analyses, traditional meta-
analytic techniques were also used to replicate the findings produced using RVE. These 
supplemental analyses yielded largely the same effects as did the RVE method. All primary 
analysis ES’s that were significant using one technique were significant using the other, and the 
ES’s themselves were also quite similar. The biggest difference between the estimated ES’s was 
for the optimism subscale. The RVE method produced a slightly larger ES estimate than did the 
analysis using one average ES per study (.011 versus .007, respectively). The subgroup analyses 
that were conducted were also similar, especially for the two subscales. Convergence of these 
two methodologies increases the confidence in the results that are reported. 
2 RVE was used to assess sensitivity whenever the empirically calculated degrees of 
freedom for the analysis was 4 or greater. Traditional meta-analytic methods, using an average 
outcome per study, were used to assess sensitivity when the degrees of freedom were less than 4. 
Traditional meta-analytic methods were also used for the remaining publication bias analyses 
that are reported. 
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Table 1. Effect size estimates for the overall/combined scale, the pessimism subscale, and the optimism subscale. 
 Optimism/Pessimism 
Overall/Combined 
Optimism Subscale Only Pessimism Subscale Only Subscale 
Differencea 
Outcomes k nb Z’ 95% CI p < k nb Z’  95% CI p < k nb Z’ 95% CI p < Z p < 
All 61 201 .026  .013, .040  .001 61 201 .011 .002, .019 .034 61 201 .029 .018, .041 .001 -2.403 .016 
Biomarkers 39 140 .030  .015, .046  .001 39 140 .006  -.008, .020  .352 39 140 .046  .030, .062  .001 -2.749 .007 
Disease 
Prevalence/ 
Incidence/ 
Progression 
 
15 
 
30 
 
.012 
 
-.009, .034  
 
.189 
 
15 
 
30 
 
.011 
 
-.008, .031  
 
.191 
 
15 
 
15┼ 
 
.008 
 
.003, .012  
 
.001 
 
-0.625 
 
.532 
Survival/ 
Mortality 
9 15 .024  -.014, .061  .162 9 9┼ .007  .002, .011  .006 9 9┼ .020  .007, .033  .004 -0.980 .327 
Hospital 
Stay/ 
Re-admit 
 
7 
 
11 
 
.002  
 
-.040, .045  
 
.899 
 
7 
 
11 
 
.018  
 
-.011, .047  
 
.161 
 
7 
 
11 
 
-.002  
 
-.062, .057 
 
.921 
 
-0.845 
 
.398 
Cardiac- 
Related 
20 71 .016  -.006, .038 .121 20 71 .014  -.007, .034 .158 20 20┼ .012  .007, .016 .001 -0.672 .502 
Metabolic 13 29 .028  .000, .056  .049 13 29 .006  -.026, .038  .672 13 13┼ .049  .035, .063 .001 -1.572 .116 
Immune 
Function 
10 10┼ .011  .004, .018  .003 10 10┼ .005  -.015, .025 .022 10 10┼ .023 .000, .046  .050 -2.293 .022 
Pulmonary 6 6┼ .008  .001, .015 .032 6 6┼ .008 .001, .015 .753 6 6┼ .011  .004, .018 .004 0.314 .753 
Pregnancy/ 
Fertility 
7 7┼ .042  .013, .071  .005 7 7┼ .010  -.031, .051 .043 7 7┼ .062  .034, .091  .001 -2.028 .043 
 
Note: aAs determined by the Wilcoxon Signed Ranks Test. bNumber of effect sizes. ┼Estimated using one effect size per study given 
empirical degrees of freedom < 4.  
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Figure 1. Flow chart showing inclusion/exclusion of studies identified from intitial search. 
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Figure 2. Forest plot of effect sizes associated with the overall/combined scale.  
 
Note: Diamond symbol at bottom of forest plot reflects average effect size across studies. 
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Figure 3. Forest plot of effect sizes associated with the optimism subscale. 
 
Note: Diamond symbol at bottom of forest plot reflects average effect size across studies. 
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Figure 4. Forest plot of effect sizes associated with the pessimism subscale. 
 
Note: Diamond symbol at bottom of forest plot reflects average effect size across studies.  
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Supplemental Online Table 2. Characteristics of studies included in the meta-analysis, outcomes assessed, and covariates controlled. 
 
 
Authors/Year Sample Characteristics Outcome Design1 Covariates 
Abdou et al. 2010 N = 297  
Mage = 31 
% female = 100 
% white = 77 
USA 
Systolic BP 
Diastolic BP 
C ethnicity, childhood SES, adult 
SES, marital status, depressive 
symptoms, perceived stress, state 
anxiety, self-esteem 
Anthony, Kritz-
Silverstein, & 
Barrett-Connor 
2016 
N = 876 
Mage = 74 
% female = 58 
% white =  
USA 
All-Cause Mortality 
CVD-Mortality 
CHD-Mortality 
Cancer-Mortality 
L 
 
Age, sex, medications 
Beckie et al. 2015 N = 252 
Mage = 63 
% female = 100 
% white = 82 
USA 
HDL-Cholesterol 
LDL-Cholesterol 
Triglycerides 
Fasting Glucose 
Body Mass Index 
Body Fat Percentage 
Systolic BP 
Diastolic BP 
Heart Rate 
C Age, sex, marital status, state-
trait anxiety, depression, self-
reported stress, anxiety, 
depression, hope 
Ben-Zur, 
Rappaport, & 
Uretzky 2004 
N = 168 
Mage = 61 
% female = 19  
% white = NA 
Israel 
Survival 
 
L Current anxiety 
Bennett et al. 
2008 
N = 87  
Mage = 13 
% female = 56 
% white = 87 
USA 
FEV1 
 
C Age, gender, SES, state anxiety, 
trait anxiety, depressive 
symptoms 
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Authors/Year Sample Characteristics Outcome Design1 Covariates 
Bleil et al. 2012 N = 204 
Mage = 35 
% female = 100  
% white = 77 
USA 
IVF Treatment Failure 
 
P 
 
Trait negative affect, age, SES, 
income, parity, duration of 
attempted pregnancy, history of 
oral medication use, history of 
injectable medication use, history 
of intrauterine insemination, 
number of infertility-related 
diagnoses. 
Boehm et al. 2013 N = 982 
Mage = 55 
% female = 55 
% white = 93 
USA 
trans-β-carotene 
13-cis-β-carotene 
α-carotene 
β-cryptoxanthin 
lutein 
zeaxanthin 
lycopene 
α-tocopherol 
γ-tocopherol 
C Age, sex, race/ethnicity, 
education, household income, 
time between assessments 
Boylan et al. 2016 N = 246 
Mage = 32 
% female = 0 
% white = 44 
USA 
Systolic BP Reactivity 
Diastolic BP Reactivity 
Heart Rate Reactivity 
HF-HRV Reactivity 
Systolic BP Recovery 
Diastolic BP Recovery 
Heart Rate Recovery 
HF-HRV Recovery 
P Age, race, child SES, marital 
status, task demand, current SES 
Catov & 
Markovic 2010 
N = 667 
Mage = 22 
% female = 100 
% white = 70 
USA 
Gestational Age 
Infant Birth Weight Centile 
L Trait affect, maternal age at 
delivery, education, marital 
status, race/ethnicity, receipt of 
public assistance, preeclampsia 
Catov et al. 2015 N = 429 
Mage = 25 
log-C-reactive protein 
log-Interleukin-6 
C Trait anxiety, maternal race, 
gestational age at blood draw, 
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Authors/Year Sample Characteristics Outcome Design1 Covariates 
% female = 100 
% white = 73 
USA 
Gestational Age Maternal age at delivery, 
education, receipt of public 
assistance, neighborhood levels 
Celano et al. 2016 N = 164  
Mage = 62 
% female = 16 
% white = 84 
USA 
C-reactive protein  
Interleukin 6 
TNF-α 
sICAM-1 
NT-proBNP 
Rehospitalization 
P Age, sex, gratitude, depression, 
anxiety, baseline biomarker 
Cohen et al. 2006 N = 193 
Mage = 37 
% female = 51 
% white = NA 
USA 
Clinical Cold Incidence 
 
P Age, sex, education, race, virus 
type, season of exposure, 
mastery, self-esteem, life 
engagement, extraversion, 
positive emotional style, negative 
emotional style 
Contrada et al. 
2004  
N = 142 
Mage = 65 
% female = 19 
% white = 84 
USA 
Length of Stay 
Postoperative Complications 
L Age, sex, marital status, 
education, anesthesia time, 
comorbidity index, depressive 
symptoms, trait hostility, 
religiousness (attendance, prayer, 
beliefs) 
Contrada et al. 
2008 
N = 550 
Mage = 65 
% female = 26 
% white = 88 
USA 
Length of Stay 
 
L 
 
Age, ethnicity (non-White), trait 
anger, anxiety, depressive 
symptoms, religious 
involvement, history of atrial 
fibrillation, duration of surgery 
Dumitrescu & 
Kawamura 
2010 
N = 79  
Mage = 41 
% female = 61 
% white = NA 
Norway 
Body Mass Index 
Total Remaining Teeth 
Plaque Index 
Calculus Index 
Bleeding on Probing Index 
Mean PD 
C Age, sex, type A, anxiety, 
depressive symptoms, emotional 
intelligence, stress, self-esteem, 
and satisfaction with life 
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Authors/Year Sample Characteristics Outcome Design1 Covariates 
Mean CAL 
Number of Sites with PD > 6mm 
Number of Sites with CAL > 5mm 
Number of Teeth with PD > 6mm 
Elavsky & 
McAuley 2009 
N = 164 
Mage = 50 
% female = 100 
% white = 83 
USA 
Body Mass Index 
 
L 
 
Age, marital status, education, 
neuroticism, trait anxiety, 
baseline body mass index 
Elliot & Chapman 
2016 
N = 1152  
Mage = 57 
% female = 57 
% white = 80 
USA 
Interleukin 6 
C-reactive protein 
L Age, sex, race, SES, chronic 
disease burden, medications, 
negative affect, positive affect, 
adult stress exposure, childhood 
stress exposure, self-esteem, 
perceived control 
Endrighi, Hamer, 
& Steptoe 2011 
N = 527 
Mage = 63 
% female = 46 
% white = NA 
UK 
Cortisol Awakening Response 
Total Daily Cortisol Output 
Cortisol Diurnal Slope 
Total Task Cortisol Output 
Cortisol Reactivity 
Cortisol Recovery 
L 
 
 
Age, sex, employment grade, 
depressive symptoms, time of 
awakening 
P 
Frain et al. 2008 N = 125 
Mage = NA 
% female = 12 
% white = NA 
USA 
CD4+ T-cell Count  C 
 
Age, years since diagnosis 
Huffman et al. 
2015 
N = 22 
Mage = 64 
% female = 41 
% white = 77 
USA 
Length of Stay 
Body Mass Index 
LVEF 
C Age, sex, race, marital status, 
anxiety, depressive symptoms, 
PANAS 
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Authors/Year Sample Characteristics Outcome Design1 Covariates 
Ikeda et al. 2011 N = 340 
Mage = 71 
% female = 0 
% white = NA 
USA 
C-reactive protein  
ICAM-1 
VCAM-1 
Interleukin 6 
TNF-RII 
P 
 
Baseline age, change in Age, 
educational attainment, brief 
symptom inventory depression 
Jackowska et al. 
2016 
N = 119 
Mage = 26 
% female = 100 
% white = 72 
UK 
Sleep Efficiency 
Sleep Latency 
Sleep Duration 
C 
 
Age, relationship status, 
ethnicity, life satisfaction, 
positive affect, negative affect, 
depressive symptoms 
Jobin, Wrosch, & 
Scheier 2014 
N = 135  
Mage = 72 
% female = 53 
% white = 80 
USA 
Average Cortisol AUC 
Average Cortisol Awakening Level 
Average Cortisol Evening Level 
P Age, sex, education, income, 
subjective social status, average 
perception of stress across days, 
outcome at wave 2.  
Kim et al. 2016 N = 70021 
Mage = 70 
% female = 100  
% white = 98 
USA 
All-Cause Mortality 
Heart Disease 
Stroke 
Respiratory Disease 
Infection 
Total Cancer 
Lung Cancer 
Breast Cancer 
Colorectal Cancer 
Ovarian Cancer 
L 
 
Age, race, marital status, 
education level, husband's 
education level, father's 
education level, depression status 
Kim et al. 2014 N = 6808 
Mage = 70 
% female = 59 
% white = 71 
USA 
Stroke Incidence 
Incident Heart Failure 
P 
 
 
 
Stroke: Age, gender, 
race/ethnicity, marital status, 
education, positive affect, 
anxiety, cynical hostility, 
depression, negative affect, 
neuroticism 
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Authors/Year Sample Characteristics Outcome Design1 Covariates 
Incident heart failure: Age, 
gender, race/ethnicity, marital 
status, education, total wealth,  
anxiety, cynical hostility, 
depression 
Knight et al. 2014 N = 54 
Mage = 47 
% female = 48 
% white = 86 
USA 
Days to Neutrophil Engraftment 
 
L 
 
Age, race, sex, conditioning 
regimen, stem cell source, 
anxiety 
Konkoly-Thege et 
al. 2015 
(Study 5) 
N = 138  
Mage = 65 
% female = 49 
% white = NA 
Hungary 
Brachial Augmentation Index 
Aortic Augmentation Index 
Aortic Pulse Wave Velocity 
Aortic Systolic Blood Pressure 
Systolic Area Index 
Diastolic Area Index 
Systolic BP 
Diastolic BP 
Mean Arterial Pressure 
Forced Vital Capacity 
FEV1 
C Sex, age, education, life 
satisfaction, general well-being, 
meaning in life, sense of 
coherence 
Konkoly-Thege et 
al. 2015 
(Study 5a) 
N = 321  
Mage = 43 
% female = 71 
% white = NA 
Hungary 
Brachial Augmentation Index 
Aortic Augmentation Index 
Aortic Pulse Wave Velocity 
Aortic Systolic Blood Pressure 
Systolic Area Index 
Diastolic Area Index 
Systolic BP 
Diastolic BP 
Mean Arterial Pressure 
Forced Vital Capacity 
FEV1 
C Sex, age, education, life 
satisfaction, general well-being, 
meaning in life, sense of 
coherence 
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Authors/Year Sample Characteristics Outcome Design1 Covariates 
Kostka & 
Jachimowicz 2010 
N = 324 
Mage = 75 
% female = 78 
% white = NA 
Poland 
Systolic BP 
Diastolic BP 
Hypertension 
Ischemic Heart Disease 
Post MI 
Diabetes 
C 
 
Age, sex, education, health locus 
of control, self-efficacy 
Lancastle & 
Boivin 2005 
N = 97 
Mage = 33 
% female = 100 
% white = NA 
UK 
Ovarian Response 
 
L 
 
Trait anxiety 
Latendresse & 
Ruiz 2010 
N = 85 
Mage = 26 
% female = 100 
% white = 69 
USA 
Low v. High CRH during Gestation 
 
C 
 
Perceived inadequacy of income, 
depressive symptoms, perceived 
stress (measured with perceived 
stress scale)* 
Lemola et al. 2010 N = 291  
Mage = 8 
% female = 51.55 
% white = NA 
Finland 
Sleep Latency 
Sleep Efficiency 
L 
 
Age, sex, parental level of 
education, parental optimism, 
self-esteem, social competence 
Low et al. 2011 N = 149  
Mage = 64 
% female = 100 
% white = NA 
USA 
CAC Progression 
 
P 
 
Age, baseline CAC, time 
between assessments, 
psychological risk (depressive 
symptoms, perceived stress, 
cynicism, anger-in), mastery, 
self-esteem 
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Authors/Year Sample Characteristics Outcome Design1 Covariates 
McDonald et al. 
2014 
N = 3021 
Mage = NA 
% female = 100 
% white = 80 
Canada 
Gestational Age 
 
P 
 
Maternal age, education, 
household income, ethnicity, 
personal/family history of pre-
term birth, reproductive history, 
mode of conception, pregnancy 
complications, poor prenatal 
care, perceived stress (measured 
with the perceived stress scale)* 
Milam et al. 2014 N = 27 
Mage = 15 
% female = 70 
% white = NA 
USA 
Hair Cortisol Levels 
 
C 
 
Perceived stress, stressful life 
events, depressive symptoms 
Minton et al. 2009 N = 47 
Mage = 74 
% female = 100 
% white = 100 
USA 
Average Cortisol AUC 
Average Cortisol Awakening Level 
Average Cortisol Evening Level 
P 
 
Age, length of marriage, 
psychological stress, life 
satisfaction, spiritual well-being, 
baseline* outcome 
Mosing et al. 2012 N = 3752 
Mage = 61 
% female = 69 
% white = NA 
Australia 
All-Cause Mortality 
 
L 
 
SES, age, sex, neuroticism, 
psychoticism, extraversion, 
social desirability 
Moyer et al. 2010 N = 141  
Mage = 30 
% female = 100 
% white = NA 
China 
Unplanned Cesarean Section 
 
P 
 
Labor duration, birth 
complications, previous abortion, 
previous miscarriage, pregnancy 
complications, self-reported 
difficulty 
O’Donovan et al. 
2009 
N = 36 
Mage = 61 
Telomere Length 
Interleukin 6 
C 
 
Age, caregiver status, perceived 
stress, neuroticism 
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Authors/Year Sample Characteristics Outcome Design1 Covariates 
% female = 100 
% white = 81 
USA 
Oliver et al. 2014 N = 72  
Mage = 19 
% female = 50 
% white = 97 
USA 
FEV1 
Body Mass Index 
 
C Age, sex, total stigma, total 
distress 
Pankalainen et al. 
2016 
N = 2719 
Mage = NA 
% female = NA 
% white = NA 
Finland 
CHD-Mortality 
 
P 
 
Age, sex, CHD at baseline 
Pankalainen, 
Kerola, & 
Hintikka 2015 
N = 1697 
Mage = NA 
% female = NA 
% white = NA 
Finland 
CHD Incidence L 
 
Age, sex 
Peters et al. 2010 N = 401 
Mage = 54 
% female = 54 
% white = NA 
Netherlands 
Length of Stay 
 
L 
 
Age, sex, type of operation, 
anatomical region 
Petros, Opacka-
Juffry, & Huber 
2013 
N = 32 
Mage = 29 
% female = 63 
% white = NA 
UK 
DHEA-S 
Cortisol 
DHEA-S / Cortisol Ratio 
C Age, gender, self-efficacy, 
anxiety, depressive symptoms 
Popa-Velea et al. 
2014 
N = 54 
Mage = 58 
% female = 48 
% white = NA 
FEV1 
 
C  
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Authors/Year Sample Characteristics Outcome Design1 Covariates 
Romania 
Price et al. 2016 N = 798 
Mage = 61 
% female = 100 
% white = NA 
Australia 
Mortality 
 
 
P 
 
Depression, age at diagnosis, 
grade at diagnosis, time since 
diagnosis, current treatment, age, 
time post-diagnosis to study 
entry 
Richman et al. 
2007 
N = 165 
Mage = 34 
% female = 45 
% white = 43 
USA 
Systolic BP Reactivity 
Diastolic BP Reactivity 
Heart Rate Reactivity 
Systolic BP Recovery 
Diastolic BP Recovery 
Heart Rate Recovery 
P 
 
Baseline outcome (for reactivity 
outcomes but not recovery 
outcomes), age, gender, 
socioeconomic status, race, 
overall hostility, cynicism, 
perceived discrimination (in past 
year and in life). 
Rohrbaugh, 
Shoham, & Coyne 
2006 
N = 189 
Mage = 53 
% female = 26 
% white = 83 
USA 
Survival - Heart Failure 
 
L 
 
Sex, marital quality, self-
efficacy, psychological distress, 
hostility, neuroticism 
Ruis-Ottenheim et 
al. 2012 
N = 1084 
Mage = 71 
% female = 36 
% white = 100 
Netherlands 
C-reactive protein  C 
 
Age, sex, marital status, history 
of cancer, history of 
cardiovascular disease, cohort (if 
appropriate) 
Ruiz et al. 2006 N = 111 
Mage = 61 
% female = NA 
% white = NA 
USA 
Number of Grafts 
Number of Vessels Occluded 50% 
Total Cholesterol 
Ejection Fraction < 40% 
Acute MI 
Angina 
 
C 
 
 
 
Age, education, employment, 
neuroticism, depressive 
symptoms, relationship 
satisfaction 
L 
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Authors/Year Sample Characteristics Outcome Design1 Covariates 
Salmoirago-
Blotcher et al. 
2016 
N = 107  
Mage = 61 
% female = 100 
% white = 85 
USA 
Patient Status (TC / MI) 
 
C Age, ethnicity, education, 
income, psychological distress, 
perceived stress, hostility, type D 
personality 
Saquib et al. 2011 N = 2967 
Mage = 53 
% female = 100 
% white = NA 
USA 
Breast Cancer 
All-Cause Mortality 
P 
L 
 
Age at randomization, 
race/ethnicity, menopausal status, 
initial tumor type, initial tumor 
stage, anti-estrogen use, clinical 
site, time between cancer 
diagnosis and study entry, hot 
flashes, randomization group, 
interaction between intervention 
group and hot flashes, marital 
status, education, hostility 
Scheier et al. 1999 N = 284 
Mage = 63 
% female = 30 
% white = 99 
USA 
Angina - Rehospitalization 
MI - Rehospitalization 
PTCA - Rehospitalization 
All-Cause Rehospitalization 
L 
 
Age, education, employment, 
neuroticism, depressive 
symptoms, relationship 
satisfaction 
Serlachius et al. 
2015 
 
N = 1113  
Mage = 32 
% female = 58 
% white = NA 
Finland 
Total Cholesterol 
Body Mass Index 
Systolic BP 
Diastolic BP 
Fasting Glucose 
P Age, sex, ideal cardiovascular 
health at baseline, medication use 
at baseline, level of education, 
occupational status, depressive 
symptoms 
Stewart et al. 2012 N = 2171 
Mage = 40 
% female = 58 
% white = 57 
USA 
CAC Progression 
 
P 
 
Age, sex, race, education, 
depression 
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Sutin 2013 N = 11207  
Mage = 68 
% female = 60 
% white = 85 
USA 
Body Mass Index 
 
C Age, sex, ethnicity, education 
 
Tindle et al.  2009 N = 97253 
Mage = 63 
% female = 100 
% white = 92 
USA 
Incident MI 
Incident CHD 
All-Cause Mortality 
CHD-Mortality 
CVD-Mortality 
Cancer-Mortality 
P 
 
 
Age, race/ethnicity, education, 
income, depressive symptoms, 
and cynical hostility 
Tindle et al. 2012  N = 430 
Mage = 65 
% female = 39 
% white = 88 
USA 
Rehospitalization 
 
L 
 
Age, sex, education, marital 
status, hamilton depression rating 
scale 
Tomakowsky et 
al. 2001 
N = 47 
Mage = 39 
% female = 0 
% white = 69 
USA 
CD4+ T-cell Count 
 
P 
 
Age, education, current 
employment status, years since 
HIV diagnosis, negative 
affectivity, baseline CD4+ T-cell 
count, duration until follow-up 
Van Allen et al. 
2015 
N = 81 
Mage = 14 
% female = 48 
% white = 89 
USA 
HbA1c 
Frequency of SMBG 
P 
 
Age, hope, baseline (Time 1) of 
the outcome variable 
Van de Rest et al. 
2010 
N = 644 
Mage = 69 
% female = 22 
% white = NA 
Netherlands 
Body Mass Index 
Systolic BP 
Diastolic BP 
Glucose 
Total cholesterol 
HDL-Cholesterol 
C Age, living alone, education, 
depressive symptoms 
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Authors/Year Sample Characteristics Outcome Design1 Covariates 
Yi-Frazier et al. 
2015 
N = 50 
Mage = 16 
% female = 52 
% white = 94 
USA 
HbA1c 
 
C Age, sex, race, education, 
income, self-esteem, diabetes-
related distress, duration of 
diabetes 
Ylostalo et al. 
2003 
N = 6033 
Mage = 31 
% female = 52 
% white = NA 
Finland 
Body Mass Index 
Total Cholesterol 
HDL-Cholesterol 
Triglycerides 
Tooth Loss 
C Life satisfaction, education, 
gender, income, marital status 
 
Note: AUC = area under the curve; BP = blood pressure; CAC = coronary artery calcium; CAL = clinical attachment level; CHD = 
coronary heart disease; CRH = corticotropin-releasing hormone; CVD = cardiovascular disease; DHEA-S = dehydroepiandrosterone 
sulfate; FEV1 = forced expiratory volume in 1 second; HbA1c = glycated hemoglobin; HDL = high-density lipoprotein; HF-HRV = high-
frequency heart rate variability; ICAM-1 = intercellular adhesion molecule 1; IVF = in-vitro fertilization; LDL = low-density lipoprotein; 
LVEF = left ventricular ejection fraction; MI = myocardial infarction; NT-proBNP = N-terminal pro b-type natriuretic peptide; PANAS = 
Positive and Negative Affect Schedule; PD = probing density; PTCA = ; sICAM-1 = soluble intercellular adhesion molecule-1; SMBG = 
self-monitoring of blood glucose; SES = socioeconomic status; TC = takotsubo cardiomyopathy; TNF-α = tumor necrosis factor alpha; 
TNFR-2 = tumor necrosis factor receptor 2; VCAM-1 = vascular cell adhesion molecule 1 
1Design of the study was coded as either cross-sectional (C), longitudinal (L), or prospective (P). 
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Supplemental Online Table 3.  Sensitivity analyses, publication bias estimates, and adjusted effect sizes. 
 
Overall/Combined Scale 
 Trim and Fill 
Outcome k Number of individual 
studies removed that 
would make  
p > .05  
Number Studies 
Trimmed/ 
Filled Left of 
Mean 
Number Studies 
Trimmed/ 
Filled Right of 
Mean 
Observed Point 
Estimate 
(95%CI) 
Adjusted Point 
Estimate 
(95%CI)  
 
All Outcomes 61 0 0 4 .026 
(.015 - .038) 
.028 
(.016 - .040) 
Biomarkers 39 0 0 2 .032 
(.017 - .046) 
.033 
(.018 - .047) 
Disease 
Prevalence/ 
Incidence/ 
Progression 
 
15 
 
NA 
 
0 
 
3 
 
.013 
(.001 - .024) 
 
.014 
(.002 - .026) 
Survival/ 
Mortality 
9 NA 0 0 .019 
(.006 - .033) 
As Observed 
Hospital Stay/ 
Re-admit 
7 NA 0 0 .002 
(-.042 - .046) 
 
As Observed 
Cardiac-
Related 
20 NA 0 2 .016 
(.003 - .030) 
.019 
(.005 - .034) 
Metabolic 13 8 0 2 .030 
(.007 - .054) 
.033 
(.012 - .054) 
Immune 
Function 
10 2* 0 1 .011 
(.004 - .018) 
.011 
(.004 - .018) 
Pulmonary 6 1* 0 1 .008 
(.001 - .015) 
.008 
(.001 - .016) 
Pregnancy/ 
Fertility 
7 1* 0 0 .042 
(.013 - .071) 
As Observed 
Pessimism Subscale 
 Trim and Fill 
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Outcome k Number of individual 
studies removed that 
would make  
p > .05 
Number Studies 
Trimmed/ 
Filled Left of 
Mean 
Number Studies 
Trimmed/ 
Filled Right of 
Mean 
Observed Point 
Estimate 
(95%CI) 
Adjusted Point 
Estimate 
(95%CI) 
All Outcomes 61 0 0 2 .029 
(.018 - .041) 
.030 
.019 -.042 
Biomarkers 39 0 0 1 .045 
(.029 - .063) 
.047 
(.036 - .062) 
Disease 
Prevalence/ 
Incidence/ 
Progression 
 
15 
 
0* 
 
0 
 
0 
 
.008 
(.003 - .012) 
 
 
As Observed 
Survival/ 
Mortality 
9 0* 0 0 .020 
(.007 - .033) 
As Observed 
Hospital Stay/ 
Re-admit 
7 NA 0 0 -.002 
(-.046 - .042) 
As Observed 
Cardiac-
Related 
20 0* 0 0 .012 
(.007 - .016) 
As Observed 
Metabolic 13 0* 0 3 .049 
(.035 - .063) 
.050 
(.036 - .064) 
Immune 
Function 
10 7* 2 0 .023 
(.000 - .046) 
.020 
(-.013 - .053) 
Pulmonary 6 5* 0 1 .011 
(.004 - .018) 
.011 
(.004 - .019) 
Pregnancy/ 
Fertility 
7 0* 0 1 .062 
(.034 - .091) 
.064 
(.035 - .093) 
Optimism Subscale 
 Trim and Fill 
Outcome k Number of individual 
studies removed that 
would make  
p > .05 
Number Studies 
Trimmed/ 
Filled Left of 
Mean 
Number Studies 
Trimmed/ 
Filled Right of 
Mean 
Observed Point 
Estimate 
(95%CI) 
Adjusted Point 
Estimate 
(95%CI)  
 
All Outcomes 61 2 4 0 .007 .007 
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(.003 - .011) (.003 - .011) 
Biomarkers 39 NA 1 0 .009 
(-.003 - .020) 
.009 
(-.003 - .020) 
Disease 
Prevalence/ 
Incidence/ 
Progression 
 
15 
 
NA 
 
0 
 
2 
 
.011 
(.000 - .020) 
 
.012 
(.001 - .022) 
Survival/ 
Mortality 
9 1* 2 0 .007 
(.002 - .011) 
.006 
(.002 - .011) 
Hospital Stay/ 
Re-admit 
7 NA 0 1 .018 
(-.026 - .062) 
.020 
(-.024 - .064) 
Cardiac-
Related 
20 NA 0 1 .013 
(.001 - .025) 
.015 
(.002- .028) 
Metabolic 13 NA 0 3 .004 
(-.026 - .035) 
.013 
(-.016 - .041) 
Immune 
Function 
10 8* 0 3 .005 
(-.015 - .025) 
.008 
(-.017 - .032) 
Pulmonary 6 NA* 0 1 .008 
(.001 - .015) 
.008 
(.001 - .016) 
Pregnancy/ 
Fertility 
7 6* 1 0 .010 
(-.031 - .051) 
.011 
(-.025 - .047) 
 
Note: NA = Not applicable because initial ES estimate was not significant. *Denotes leave one out analysis was based on traditional meta-
analytic methodology using one average effect size per study. The remainder of the leave one out analyses were conducted using RVE. 
Number of studies trimmed and filled and adjusted effect sizes are based on traditional meta-analytic methodology using one average 
effect size per study. 
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Online Supplemental Figure 1. Funnel plot for effects involving the overall/combined scale. 
 
 
 
 
 
 
Note: Open circles represent observed values and filled circles represent values imputed in order 
to correct for potential publication bias. 
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Supplemental Online Figure 2. Funnel plot for effects involving the pessimism subscale. 
 
 
 
 
 
 
Note: Open circles represent observed values and filled circles represent values imputed in order 
to correct for potential publication bias. 
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Supplemental Online Figure 3. Funnel plot for effects involving the optimism subscale. 
 
 
 
 
 
 
Note: Open circles represent observed values and filled circles represent values imputed in order 
to correct for potential publication bias. 
 
 
 
